These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1961194)

  • 1. [Serum levels of c-erbB-2 protein in patients with breast cancer: preliminary report].
    Ohuchi N; Abe M; Harada Y; Furuta A; Ikegaki H; Mori S
    Nihon Geka Gakkai Zasshi; 1991 Oct; 92(10):1530. PubMed ID: 1961194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of sandwich radioimmunometric assay for serum c-erbB-2 oncogene product and its significance in diagnosing breast carcinoma].
    Yu FZ; Sugano K; Ohkura H; Mori S
    Rinsho Byori; 1991 Oct; 39(10):1087-92. PubMed ID: 1684826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
    Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
    Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of soluble c-erbB-2 protein in serum of gastric cancer patients: preliminary report].
    Nakai M; Yonemura Y; Tsugawa K; Fushida Y; Yamaguchi A; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):337. PubMed ID: 1355258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum levels of c-erbB-2 protein in patients with lung adenocarcinoma: preliminary report].
    Ohsaki T; Mitsudomi T; Oyama T; Kodate M; Nakanishi R; Shirakusa T
    Nihon Geka Gakkai Zasshi; 1993 Mar; 94(3):320. PubMed ID: 8100349
    [No Abstract]   [Full Text] [Related]  

  • 6. [C-erb B-2 protein in the sera of breast cancer patients].
    Narita T; Funahashi H; Satoh Y; Takagi H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):909-11. PubMed ID: 1351384
    [No Abstract]   [Full Text] [Related]  

  • 7. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study.
    Streckfus C; Bigler L; Dellinger T; Dai X; Kingman A; Thigpen JT
    Clin Cancer Res; 2000 Jun; 6(6):2363-70. PubMed ID: 10873088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of C-erbB-2 protein in breast cancer tissue by enzyme-immunoassay: preliminary report].
    Narita T; Funahashi H; Sato Y; Imai T; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):661. PubMed ID: 8101962
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum c-erbB-2 protein in breast cancer patients.
    Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S
    J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. erbB-2 and myc oncoproteins in sera and tumors of breast cancer patients.
    Breuer B; De Vivo I; Luo JC; Smith S; Pincus MR; Tatum AH; Daucher J; Minick CR; Miller DG; Nowak EJ
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):63-6. PubMed ID: 7906981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer.
    Belgore FM; Lip GY; Bareford D; Wadley M; Stonelake P; Blann AD
    Am J Hematol; 2001 Jan; 66(1):59-61. PubMed ID: 11426496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP; Strickler JG
    Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial serum c-erbB-2 levels in patients with breast carcinoma.
    Volas GH; Leitzel K; Teramoto Y; Grossberg H; Demers L; Lipton A
    Cancer; 1996 Jul; 78(2):267-72. PubMed ID: 8674002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
    Meenakshi A; Kumar RS; Kumar NS
    J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary studies on c-erbB-2 protooncogene in breast cancer].
    He LW
    Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):171-4. PubMed ID: 1356719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
    Hynes NE; Gerber HA; Saurer S; Groner B
    J Cell Biochem; 1989 Feb; 39(2):167-73. PubMed ID: 2565909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of immunohistochemically detected c-erbB-2 protein expression in stage III breast cancer, with reference to nuclear deformity, DNA content and prognosis.
    Tamura G; Maesawa C; Mikawa S; Satodate R
    Jpn J Clin Oncol; 1991 Aug; 21(4):264-7. PubMed ID: 1682519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
    Berger MS; Locher GW; Saurer S; Gullick WJ; Waterfield MD; Groner B; Hynes NE
    Cancer Res; 1988 Mar; 48(5):1238-43. PubMed ID: 2893663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.